AbbVie Inc.ABBVNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+3.6%
5Y CAGR+11.5%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+3.6%/yr
vs +13.2%/yr prior
5Y CAGR
+11.5%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 46.26% | +74.8% |
| 2024 | 26.47% | -16.3% |
| 2023 | 31.61% | -24.1% |
| 2022 | 41.64% | -2.2% |
| 2021 | 42.59% | +58.3% |
| 2020 | 26.90% | -26.8% |
| 2019 | 36.76% | +44.9% |
| 2018 | 25.37% | -31.0% |
| 2017 | 36.78% | -6.8% |
| 2016 | 39.47% | - |